Abstract
Reduced graphene oxide-zinc oxide (RGO–ZnO) composite was facilely fabricated by a spontaneous reduction of graphene oxide via zinc slice in one-pot approach at room temperature, and used to modify glassy carbon electrode (GCE) for developing of electrochemical biosensor (RGO–ZnO/GCE). The as-prepared RGO–ZnO was characterized by X-ray diffraction (XRD), X-ray photoelectron spectroscopy (XPS), inductively coupled plasma atomic emission spectroscopy (ICP-AES), scanning electron microscopy (SEM) and transmission electron microscope (TEM). It was revealed that the existence of ZnO in RGO–ZnO/GCE largely enhanced the electroactive surface area (EASA) and therefore the sensitivity for electrochemical sensing. In the mixtures of ascorbic acid (AA), dopamine (DA) and uric acid (UA), the biosensor exhibited three well-resolved voltammetric peaks (ΔEAA–DA=236mV, ΔEDA–UA=132mV, ΔEAA–UA=368mV) in the differential pulse voltammetry (DPV) measurements, allowing a simultaneous electrochemical detection of these biomolecules. The liner relationships between current intensities and concentrations were found to be 50–2350μM, 1–70μM and 3–330μM, with detection limits of 3.71μM, 0.33μM and 1.08μM for AA, UA and DA, respectively. The as-prepared RGO–ZnO/GCE biosensor displayed a good reproducibility and stability and was applied for detection of of AA, DA and UA in real plasma and urine samples with satisfying results.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.